Clinical Trial

Comparison of Intralesional Triamcinolone Acetonide Treatment With Intralesional Verapamil Hydrochloride in Keloids

Completed
View on ClinicalTrials.gov →
Summary
The paucity of local literature regarding the comparison of intralesional verapamil with intralesional triamcinolone acetonide led this study to be carried out with the objective of comparing the clinical effectiveness of intralesional triamcinolone acetonide and intralesional verapamil hydrochloride in patients with keloids.
Trial Details
NCT Number NCT07420166
Lead Sponsor Muhammad Aamir Latif
Conditions Keloid
Enrollment 60 participants
Start Date 2025-01-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-19